Page last updated: 2024-08-23

azoxymethane and atorvastatin

azoxymethane has been researched along with atorvastatin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khor, TO; Kong, AN; Kopelovich, L; Rao, CV; Reddy, BS; Steele, VE; Wang, CX; Zheng, X1
DeCastro, A; Janakiram, NB; Lee, HJ; Paul, S; Rao, CV; Reddy, BS; Simi, B; Smolarek, AK; So, JY; Steele, V; Suh, N; Wang, CX1
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z1
Cai, X; Gao, Z; Li, F; Qiu, P; Rakariyatham, K; Song, M; Wang, M; Wu, X; Xiao, H; Xu, F; Zheng, J1

Other Studies

4 other study(ies) available for azoxymethane and atorvastatin

ArticleYear
Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Cancer research, 2006, Apr-15, Volume: 66, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aspirin; Atorvastatin; Azoxymethane; Carcinogens; Celecoxib; Cell Growth Processes; Colonic Neoplasms; Dose-Response Relationship, Drug; Heptanoic Acids; Male; Pyrazoles; Pyrroles; Rats; Rats, Inbred F344; Sulfonamides

2006
Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:11

    Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclin D1; eIF-2 Kinase; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunoenzyme Techniques; Interleukin-4; Male; Naproxen; Nitric Oxide Synthase Type II; Pyrroles; Rats; Rats, Inbred F344; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha

2011
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
    Nutrition and cancer, 2012, Volume: 64, Issue:6

    Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss

2012
Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
    Carcinogenesis, 2017, 04-01, Volume: 38, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Atorvastatin; Azoxymethane; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Flavones; HT29 Cells; Humans; Male; Mice; Rats; Rats, Inbred F344

2017